Core Viewpoint - A class action lawsuit has been filed against Sarepta Therapeutics, Inc. for misleading statements regarding the safety and efficacy of its gene therapy product, ELEVIDYS, during the specified Class Period from June 22, 2023, to June 24, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Sarepta made false and misleading statements about ELEVIDYS, which is intended for patients with Duchenne muscular dystrophy, including significant safety risks and failure to detect severe side effects [5]. - It is alleged that the adverse events from ELEVIDYS treatment would lead to a halt in recruitment and dosing in trials, regulatory scrutiny, and increased risk regarding the therapy's approvals [5]. - Investors are encouraged to join the class action to seek compensation without upfront costs through a contingency fee arrangement [2][3]. Group 2: Legal Representation - The Rosen Law Firm, known for its success in securities class actions, is representing the investors and has a strong track record, including recovering hundreds of millions for investors [4]. - Investors are advised to select qualified legal counsel with a proven history in similar cases, as not all firms have comparable experience or resources [4]. Group 3: Next Steps for Investors - Interested investors can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. - It is noted that no class has been certified yet, and investors may choose to remain absent or select their own counsel [7].

Here’s How Sean ‘Diddy’ Combs’ Criminal Conviction Could Help Plaintiffs In His Dozens Of Civil Lawsuits https://t.co/Zfdp2vVs1p https://t.co/Zfdp2vVs1p ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased PepGen Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on August 8, 2025, for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought PepGen securities between March 7, 2024, and March 3, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by the deadline [2]. - The Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [3]. Group 2: Case Allegations - The lawsuit alleges that PepGen made false and misleading statements regarding the effectiveness and safety of PGN-EDO51, as well as the CONNECT2 study's suitability for FDA approval [4]. - It is claimed that due to these misrepresentations, PepGen was likely to halt the CONNECT2 study, leading to overstated clinical, regulatory, and commercial prospects for PGN-ED051 [4]. - The lawsuit asserts that when the true information became public, investors suffered damages as a result of the misleading statements [4]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong reputation in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [3]. - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions for investors [3]. - In 2019, the firm secured over $438 million for investors, showcasing its effectiveness in litigation [3].

Core Viewpoint - A securities class action lawsuit has been filed against Elevance Health, Inc. for alleged misrepresentation of financial guidance and cost trends related to Medicaid redetermination processes during the specified Class Period [1][4][5]. Company Overview - Elevance Health, Inc. is a healthcare company based in Indianapolis, Indiana, providing health insurance plans and administering Medicaid benefits for eligible beneficiaries [3]. Lawsuit Details - The lawsuit claims that Elevance misled investors by stating they were effectively monitoring cost trends and that premium rates negotiated with states were sufficient to cover rising Medicaid expenses [4]. - It is alleged that the company did not adequately reflect the impact of Medicaid redeterminations, which resulted in a higher utilization of Medicaid members who remained eligible, as those removed were generally healthier [5]. Investor Information - Investors who purchased Elevance securities during the Class Period have until July 11, 2025, to seek appointment as lead plaintiff representatives [2].

Here’s How Sean ‘Diddy’ Combs’ Criminal Conviction Could Help Plaintiffs In His Dozens Of Civil Lawsuits https://t.co/7ypJIGVLdq https://t.co/7ypJIGVLdq ...

The victory you got for Jay-Z seemed like classic you. You got the case dismissed. You're coming back with a defamation suit.You called the accuser's lawyer a 1800 lawyer. Why were you so aggressive in defending him. Cuz he was completely innocent and because I felt that the system was being weaponized in an improper way.And what does that tell you about the system. The system is very broken. It's probably, you know, we spend so much time talking about other things, but it is one of the original problems in ...

Here’s How Sean ‘Diddy’ Combs’ Criminal Conviction Could Help Plaintiffs In His Dozens Of Civil Lawsuitshttps://t.co/umYC5xt9nD https://t.co/ZdRE71a1TT ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Reddit, Inc. regarding a class action lawsuit alleging that the company made materially false and misleading statements during a specified class period, which has impacted shareholder value [1][2]. Allegations - The lawsuit claims that during the class period from October 29, 2024, to May 20, 2025, Reddit's management failed to disclose significant changes in Google Search's algorithm that led to a decline in user traffic to Reddit [1]. - It is alleged that the changes in Google's algorithm, including features like AI Overview, caused users to stop their queries on Google Search, which was not previously experienced [1]. - The complaint states that the increase in search queries for "Reddit" was misleading, as users were finding answers directly from Google without visiting Reddit, indicating a zero-click search phenomenon that adversely affected Reddit's traffic [1]. - The defendants are accused of lacking a reasonable basis for their forecasts on user rates and advertising revenues, leading to materially false public statements [1]. Next Steps for Shareholders - Shareholders who purchased RDDT shares during the class period are encouraged to register for the class action by August 18, 2025, to potentially become lead plaintiffs [2]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the case lifecycle, with no cost or obligation to participate [2]. About the Law Firm - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud, ensuring companies adhere to responsible business practices [3].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Fortrea Holdings Inc. regarding a class action lawsuit alleging that the company made materially false and misleading statements about its financial projections and business model during the specified class period [1][2]. Allegations - The complaint claims that Fortrea overestimated the revenue contributions from its long-term projects, known as the Pre-Spin Projects, for the year 2025 [1]. - It is alleged that Fortrea overstated the cost savings expected from exiting transition services agreements [1]. - The company's previously announced EBITDA targets for 2025 were inflated as a result of these misstatements [1]. - The viability of Fortrea's post-spin-off business model and its financial prospects were also overstated [1]. - Consequently, the public statements made by the company were materially false and misleading throughout the relevant period [1]. Class Action Details - The class period for the lawsuit is from July 3, 2023, to February 28, 2025 [1]. - Shareholders are encouraged to register for the class action by August 1, 2025, to potentially be appointed as lead plaintiffs [2]. - Registered shareholders will receive updates through a portfolio monitoring software regarding the case's progress [2]. Firm's Mission - The Gross Law Firm aims to protect the rights of investors who have suffered losses due to deceitful practices and seeks recovery for those affected by misleading statements that artificially inflated stock prices [3].

NEW YORK, July 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Compass Group Diversified Holdings, LLC (NYSE: CODI).Shareholders who purchased shares of CODI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/compass-diversified-loss-submission-form/?id=155230&from=4CLASS PERI ...